Two Ghanaian Pharmaceutical operators have been elected to serve on the Board of the Africa Pharmaceutical Distribution Association (APDA) for contributing towards the growth of the pharmaceutical industry on the continent, ABC News can report.
The two- Mr. Kofi Addo-Agyekum, Chief Executive Officer of Kofikrom Pharmacy Ltd, and Mr. Anthony Kwaku Ameka, the Chief Executive Officer of the Chamber of Pharmacy Ghana- are to serve as Vice-Chairman and Member of the Board respectively.
Additionally, Mr Anthony Ameka will serve as Chairman of a newly constituted Finance Committee of the Board.
They were elected at the 3rd Constituent Assembly of the APSA recently held in Casablanca, Morocco.
The Board, chaired by Mr. Lahcen Senhaji from Morocco also has Mr. Ken Accajou from Gabon as co-chairman, with other elected executives from Egypt, Tunisia, Nigeria, South Africa, Rwanda and Algeria.
Specially co-opted organizations to assist the Board in its work includes IFPW (USA), IQVIA and Advantage Health from France and Nigeria respectively.
All the elected Board members and the executives have a two-year mandate to run the affairs of the Association from 2019 to 2021 after which new executives will be elected to take up the mantle.
The Africa Pharmaceutical Distribution Association (APDA) has been formed to address all strategic and advocacy issues on pharmaceutical supply chain in Africa.
ADPA’s objective is to participate in the promotion and development of universal standards among African populations in the pharmaceutical distribution sector in particular and the health sector in general.
Available statistics suggest that globally, medicines spending reached $1.2 trillion in 2018, from $1.1T in 2017 and is set to be just under $1.3T by 2019, with 4–5% global growth.
Africa and other Pharma emerging markets are regarded as the key engines for growth, with Africa expected to drive $19bn of the global pharmaceutical market by 2022.
The Constituent Assembly therefore provided an opportunity for participants from 16 African countries to discuss “means and action”, likely to ensure greater participation in organizing medication distribution circuit and health products in Africa”.
The action includes ensuring, constantly, the quality of storage and delivery of medicines for Africans, exploring ways to enhance service and service delivery, strategies to drive down logistic costs and comprehensive support to enhance security, safety and integrity of the pharmaceutical supply chain in Africa.
The meeting also discussed ways to tackle unethical practices, the circulation of falsified or counterfeited medication as well as any act of non-compliance with the regulatory provisions for the pharmaceutical supply chain in Africa.